Nine Point Two Capital LLC Incyte Corp Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Incyte Corp stock. As of the latest transaction made, Nine Point Two Capital LLC holds 3,253 shares of INCY stock, worth $191,992. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,253Holding current value
$191,992% of portfolio
0.08%Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
617Shares Held
215MCall Options Held
366KPut Options Held
445K-
Baker Bros. Advisors LP New York, NY36.2MShares$2.14 Billion26.1% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$1.37 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$1.34 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA15.4MShares$910 Million0.54% of portfolio
-
State Street Corp Boston, MA9.9MShares$584 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $13.1B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...